NASDAQ : QDEL

QuidelOrtho Corporation — Company profile

Healthcare · Medical Devices · United States

Last price 13.25 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 908.62M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Company profile

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point of Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, to measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point of Care business unit provides instruments and tests to provide rapid results across a continuum of POC settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, Japan and Asia Pacific, and Latin America. The company was incorporated in 1979 and is headquartered in San Diego, California.

Details

NameQuidelOrtho Corporation
SectorHealthcare
IndustryMedical Devices
Employees6500
Founded1979
CeoBrian Blaser
CountryUnited States
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IsinUS2197981051
Cusip219798105
Cik1906324
Sic2835
Stock TypeCommon Stock

Key executives

NameTitle
Brian J. BlaserPresident, Chief Executive Officer and Director
Philip D. McLellanChief Operations Officer
Jonathan P. Siegrist Ph.D.Executive Vice President of Research and Development and Chief Technology Officer
Micah Young CPAChief Financial Officer and Principal Financial Officer
Juliet C. CunninghamVice President of Investor Relations
Nathaniel B. Sisitsky Esq.Chief Legal Officer and Corporate Secretary
Lisa S. HayesVice President of Global Marketing and Corporate Communications
Bryan M. HansonExecutive Vice President of Global Portfolio Management and Marketing
Erich WolffExecutive Vice President of Strategy and Corporate Development
Ronald Lee BowmanChief Human Resources Officer

Contact

Address9975 Summers Ridge Road, San Diego, California 92121, United States
Phone858 552 1100
Websitehttps://www.quidelortho.com